RESOURCES

Researcher, Dr. Martin King, discovers RxFibers' RxFibron HT™ High-Tenacity PET has superior properties to standard PET and UHMWPE for soft tissue applications - Research findings were recently presented by Dr. King of NCSU at the annual Society for Biomaterials 2014 Annual Meeting: Pioneering the Future of Biomaterials. To hear Dr. King's presentation, click "continue reading" to watch the video. Continue reading...

RxFiber, LLC today announced that its high tenacity, next generation biomaterial for implantable medical devices, RxFibron HT^TM, has been selected as a Golden Mousetrap Winner in the Materials and Assembly category. The Awards celebrate the companies, products, and people who are energizing North American design, engineering, and manufacturing. During a live ceremony, RxFiber’s President, Robert Torgerson, was presented the 2013 Golden Mousetrap Award on February 11, 2014. Continue reading...

The next generation in medical-grade fibers, RxFibron HT^TM is the first medical-grade PET to exhibit high-tenacity properties without compromising strength for developing low-profile devices. Continue reading...

In this feature, Robert Torgerson draws from his experience working as a senior engineer in the medical device industry and more recently, as the president of medical-grade fiber maker RxFiber, to offer advice on using biomaterials in ground-breaking medical device projects. Continue reading...

The use of foreign materials in the human body has an impressively long history. In approximately 600 A.D, the Mayans used mother of pearl to fashion dental implants that apparently integrated with bone. An iron dental implant dating back to 200 A.D. has been found in Europe. The use of sutures has an even longer history, stretching back some 32,000 years. Fast forwarding through the centuries, elephant ivory was used to fashion the first documented hip implant in 1891. Most biomaterials used over the course of history were intended to be biopassive—simply tolerated by the body. This is beginning to change, however, as there is increasing demand to create biomaterials that support the field of regenerative medicine. In the meantime, inert biomaterials are also continuing to evolve. Continue reading...